https://www.targetedonc.com/view/cholangiocarcinoma-awareness-day-advances-in-frontline-and-later-btc-therapies
0
0
2/12/23 at 12:00pm
Organization
Targetedonc.com
Author
Jonah Feldman
40 words
0
Comments
In an interview with Targeted Oncology™, Nathan Bahary, MD, PhD, discussed adapting to new therapy options and what the future holds for improving care for patients with cholangiocarcinoma.
You are the first to view
Create an account
or login to join the discussion